child in wheelchair

New trial could save the eyesight of children with rare genetic disease

Great Ormond Street hospital in London have begun trials for a new drug which they believe could be the key to stopping loss of eyesight in children who have CLN2-type Batten Disease.

Batten Disease affects only 50 children in the UK and is a rare genetic disease which causes seizures and eventual loss in vision, inability to walk, speak or see.

50 children in uk have batten disease

Without treatment, life expectancy for children with the disease is between 10 and 12 years.

The new trial treatment restores enzymes that allow the eye to function, which clinicians hope will be successful in restoring vision.

Dr Paul Gissen, an honorary consultant in paediatric metabolic diseases at Great Ormond Street hospital, in an interview with the Guardian said: “The enzyme replacement therapy given into the brain has completely changed the lives of children with CLN2-type Batten disease for the better, but it has been difficult to watch their sight deteriorate even as their other physical symptoms are more controlled.

“The multi-disciplinary team at GOSH has been working hard to find a way to try to treat this and it’s only been possible thanks to the fundraising and tireless work of the patients’ families.”

An eight-year-old girl from Cheshire has become the first person to receive the treatment in the world.

Batten Disease is a hereditary condition which siblings of affected individuals have a 25 percent chance of having.

Both Amelia Carroll and her brother Ollie have the genetic disease. Unfortunately, due to Ollie being older, his eyesight has already deteriorated too far to benefit from the trial treatment.

There is currently no funding from the NHS for the trial and so far has been privately funded by affected families..

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all